logo

For the Inventor, By the Inventor

Urawa, Japan

Hiromichi Nakajima

This inventor holds 10 USPTO granted patents. Top assignee: Tanabe Seiyaku Company, Limited. Active years: 1976-1987.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hiromichi Nakajima. Retrieved from https://idiyas.com/inventor/hiromichi-nakajima

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10

% Patents Active = 100.0

Average Co-Inventor Count = 4.6

ph-index = 4

Forward Citations = 93(Granted Patents)


Location History:

  • Yono, JA (1976 - 1978)
  • Yono, JP (1978)
  • Urawa, JP (1985 - 1987)

Company Filing History:

goldMedal10 out of 324 
 
Tanabe Seiyaku Company, Limited
 patents

Years Active: 1976-1987

Loading Chart...
10 patents (USPTO):Explore Patents
1. 4665068 - Novel 9-chloro-1,5-benzothiazepine derivatives and their pharmaceutical (1987-05-12),
2. 4594342 - 1,5-benzothiazepine derivative (1986-06-10),
3. 4590188 - 1,5-benzothiazepine derivatives and their pharmaceutical use (1986-05-20),
4. 4585768 - 1,5-benzothiazepine derivatives and processes for preparing the same (1986-04-29),
5. 4567175 - 8-Chloro-1,5-benzothiazepine derivatives (1986-01-28),
6. 4521430 - 1,5-Benzothiazepin-4-one, their pharmaceutical compositoins, and methods (1985-06-04),
7. 4131686 - Novel benzylalcohol derivatives and processes for preparing the same (1978-12-26),
8. 4072759 - Novel benzylalcohol derivatives as antidiabetics and cardiotonics (1978-02-07),
9. 4032575 - Benzylalcohol amine derivatives (1977-06-28),
10. 3952021 - .alpha.-(3,4-Dimethoxyphenethylaminomethyl)-3,4 or (1976-04-20),

Title: Hiromichi Nakajima: Innovator in Pharmaceutical Chemistry

Introduction

Hiromichi Nakajima is a prominent inventor based in Urawa, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on benzothiazepine derivatives. With a total of 10 patents to his name, Nakajima's inventions have the potential to impact medical treatments significantly.

Latest Patents

Among his latest patents, Nakajima has developed novel 9-chloro-1,5-benzothiazepine derivatives. These compounds are disclosed as useful hypotensive agents and/or cerebral or coronary vasodilators. His work includes a specific 1,5-benzothiazepine derivative, characterized by the formula: ##STR1##, where R.sup.1 is hydrogen or lower alkanoyl, and each of R.sup.2 and R.sup.3 is lower alkyl. This innovative derivative and its pharmaceutically acceptable acid addition salts represent a significant advancement in therapeutic options.

Career Highlights

Hiromichi Nakajima is associated with Tanabe Seiyaku Company, Limited, where he continues to push the boundaries of pharmaceutical research. His career is marked by a commitment to developing effective medical solutions that address critical health issues.

Collaborations

Throughout his career, Nakajima has collaborated with notable colleagues, including Taku Nagao and Mikio Takeda. These partnerships have fostered a collaborative environment that enhances the innovation process.

Conclusion

Hiromichi Nakajima's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a key innovator in the field. His work continues to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…